The Latest Evidence of Endovascular Therapy for Femoropopliteal Lesions

Abstract

Over 20 million people are estimated to suffer from peripheral artery disease (PAD) and its morbidity will grow rapidly in the world. 50-70% of patients with symptomatic PAD have femoropopliteal (FP) disease. In FP region, the recommendations for EVT are different in several guidelines, because of remarkable progress in new techniques and devices of endovascular therapy (EVT). Therefore, the standardization for FP-EVT has not yet been established. We introduce the current indications and EVT procedures, and review the latest evidence of new devices.